Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

SONN Sonnet BioTherapeutics Holdings Inc

2,98

0,09 (3,11%)

23 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form ARS - Annual Report to Security Holders

Sonnet BioTherapeutics (NASDAQ:SONN)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Sonnet BioTherapeutics Charts.

Sonnet BioTherapeutics (NASDAQ:SONN)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Sonnet BioTherapeutics Charts.

News Sonnet BioTherapeutics Holdings Inc

Sonnet BioTherapeutics Releases Virtual Investor ‘”What this Means” Segment
Dienstag 12 November 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 8 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 424B4 - Prospectus [Rule 424(b)(4)]
Donnerstag 7 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Donnerstag 7 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules
Mittwoch 6 November 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mittwoch 6 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 6 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel Immunotherapeutic Drug Candidates
Mittwoch 6 November 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Montag 4 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Montag 28 Oktober 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 17 Oktober 2024 (1 Monat vor) • Edgar (US Regulatory)

Sonnet BioTherapeutics Inc. Regains Compliance with Nasdaq
Donnerstag 17 Oktober 2024 (1 Monat vor) • GlobeNewswire Inc.

Weitere Sonnet BioTherapeutics Holdings Inc News-Artikel

Deutsche Telekom (QX)

JP Morgan Chase

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen